A randomised, multi-centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol

David R. Cornblath, Hans-Peter Hartung, Hans D. Katzberg, Ingemar S. J. Merkies, Pieter A. van Doorn

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)108-114
Number of pages7
JournalJournal of the Peripheral Nervous System
Volume23
Issue number2
DOIs
Publication statusPublished - 1 Jun 2018

Keywords

  • chronic inflammatory demyelinating polyradiculoneuropathy
  • intravenous immunoglobulin
  • randomised-controlled trial
  • study design
  • trial protocol
  • DOUBLE-BLIND
  • POLYNEUROPATHY
  • NEUROPATHIES

Cite this